These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12736978)

  • 1. Surveillance of meningococcal disease in South Island, New Zealand.
    Holmes J
    Commun Dis Public Health; 2003 Apr; 6(1):68; author reply 68-9. PubMed ID: 12736978
    [No Abstract]   [Full Text] [Related]  

  • 2. The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
    Sexton K; Lennon D; Oster P; Crengle S; Martin D; Mulholland K; Percival T; Reid S; Stewart J; O'Hallahan J
    N Z Med J; 2004 Aug; 117(1200):U1015. PubMed ID: 15475985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine.
    Bremner C; Lennon D; Martin D; Baker M; Rümke H
    N Z Med J; 1999 Jul; 112(1091):257-9. PubMed ID: 10448985
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal disease.
    Charlton R
    N Z Med J; 1999 Jun; 112(1090):241. PubMed ID: 10449004
    [No Abstract]   [Full Text] [Related]  

  • 5. Meningococcal disease 1992.
    N Z Med J; 1992 Sep; 105(942):389. PubMed ID: 1436853
    [No Abstract]   [Full Text] [Related]  

  • 6. The deathly progress of meningococcal disease.
    Prentice D; Hathaway M
    Nurs N Z; 2001 Jun; 7(5):18. PubMed ID: 12012896
    [No Abstract]   [Full Text] [Related]  

  • 7. Meningococcal disease epidemiology and control in New Zealand.
    Wilson N; Baker M; Martin D; Lennon D; O'Hallahan J; Jones N; Wenger J; Mansoor O; Thomas M; Jefferies C
    N Z Med J; 1995 Oct; 108(1010):437-42. PubMed ID: 7478351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social context of meningococcal disease.
    Charlton R
    Lancet; 1998 Oct; 352(9135):1227. PubMed ID: 9777870
    [No Abstract]   [Full Text] [Related]  

  • 9. Invasive meningococcal disease in Northland, New Zealand.
    Mills C
    N Z Med J; 2011 Dec; 124(1347):95-7. PubMed ID: 22237578
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningococcal disease.
    Charlton R
    N Z Med J; 1998 Aug; 111(1072):326-7. PubMed ID: 9765636
    [No Abstract]   [Full Text] [Related]  

  • 11. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auckland gears up for meningococcal epidemic.
    Coney S
    Lancet; 1998 May; 351(9115):1567. PubMed ID: 10326555
    [No Abstract]   [Full Text] [Related]  

  • 13. Meningococcal vaccine.
    Tukuitonga C
    N Z Med J; 2001 Dec; 114(1145):557. PubMed ID: 11833953
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal disease in Auckland, July 1992 - June 1994.
    Jefferies C; Lennon D; Stewart J; Martin D
    N Z Med J; 1999 Apr; 112(1085):115-7. PubMed ID: 10326799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling the tapestry of meningococcal disease.
    Heaton P
    N Z Med J; 1999 Sep; 112(1096):366-7. PubMed ID: 10587059
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningococcal B immunisation in New Zealand: why haven't we seen the data?
    Bolland M
    N Z Med J; 2008 Mar; 121(1270):107-9. PubMed ID: 18364764
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand.
    Lennon D; Gellin B; Hood D; Voss L; Heffernan H; Thakur S
    Pediatr Infect Dis J; 1992 Aug; 11(8):617-23. PubMed ID: 1523071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
    Arnold R; Galloway Y; McNicholas A; O'Hallahan J
    Vaccine; 2011 Sep; 29(40):7100-6. PubMed ID: 21803101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.